EGFR is one of the ErbB category of receptor tyrosine kinases

EGFR is one of the ErbB category of receptor tyrosine kinases and it is connected with worse prognosis in mind and throat squamous cell carcinoma (HNSCC). level 1 proof that cetuximab boosts overall success when coupled with cisplatinum and 5 FU. Pursuing progression on initial line chemotherapy many phase II studies claim that cetuximab monotherapy… Continue reading EGFR is one of the ErbB category of receptor tyrosine kinases